Bitcoin Miner Bitfarms, Frontier Communications, and More Stocks See Action From Activist Investors -- Barrons.com
HC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $13 Price Target
H.C. Wainwright Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $13
H.C. Wainwright analyst Robert Burns maintains $Tango Therapeutics(TNGX.US)$ with a buy rating, and maintains the target price at $13.According to TipRanks data, the analyst has a success rate of 26.9
Tango Therapeutics: A Buy Rating Amidst Competitive Advantages and Promising Market Valuation
Small U.S. Stocks Finish Mixed As Xencor Lead, Tango Therapeutics Lags
Piper Sandler Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $18
Piper Sandler analyst Joseph Catanzaro maintains $Tango Therapeutics(TNGX.US)$ with a buy rating, and maintains the target price at $18.According to TipRanks data, the analyst has a success rate of 44